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Drug delivery bymicro- and nano-carriers enables controlled transport of pharmaceuticals to targeted sites.
Even though carrier fabrication has mademuch progress recently, the delivery including controlled particle
distribution and adhesion within the body remains a great challenge. The adhesion of carriers is strongly
affected by their margination properties (migration toward walls) in the microvasculature. To investigate
margination characteristics of carriers of different shapes and sizes and to elucidate the relevant physical
mechanisms, we employ mesoscopic hydrodynamic simulations of blood flow. Particle margination is
studied for a wide range of hematocrit values, vessel sizes, and flow rates, using two- and three-dimensional
models. The simulations show that the margination properties of particles improve with increasing carrier
size. Spherical particles yield slightly better margination than ellipsoidal carriers; however, ellipsoidal
particles exhibit a slower rotational dynamics near a wall favoring their adhesion. In conclusion,
micron-sized ellipsoidal particles are favorable for drug delivery in comparison with sub-micron spherical
particles.
T
he use of targeted micro- and nano-carriers for the delivery of imaging agents and drugs provides a
promising strategy for early detection and treatment of diseases, e.g., of cancer1,2. However, the design of
particles carrying different contrast agents and drugs as well as their physical delivery are very challenging
tasks. Micro- and nano-particle fabrication, which needs to address several issues such as bio-compatibility,
durability, binding to specific targets, and the ability of controlled release, has been strongly advanced in recent
years3–7. Nevertheless, the development of efficient strategies for the delivery of carriers, including their distri-
bution in the organism following systemic administration8 and their transport through biological barriers8–10 (e.g.,
microvascular walls, interstitial space, and cell membranes), requires a much more detailed understanding of the
relevant physical and biological mechanisms2,8,11,12.
Successful delivery of micro- and nano- carriers strongly depends on their efficient binding to specific targeted
sites. Consequently, the distribution of carriers within vessel cross-sections plays an important role, since binding
of carriers is only possible in case of direct particle-wall interactions. The cross-sectional distribution of micro-
and nano-particles depends on several relevant parameters, which concern blood flow properties (such as flow
rate, red blood cell deformability, and hematocrit – the volume fraction of red blood cells), vessel size, and particle
characteristics (such as size, shape, and deformability). The migration of various suspended particles or cells
toward walls in blood flow, which is often referred to asmargination, has been observed experimentally for white
blood cells13,14, platelets15,16, and rigid micro-particles17,18. Particle margination is mediated by red blood cells
(RBCs), whichmigrate to the vessel center19 due to hydrodynamic interactions with the walls (called lift force)20,21
leading to a RBC-free layer near the walls. More precisely, the occurrence of margination is a consequence of the
competition between lift forces on RBCs and suspended particles, and their interactions in flow22. However, the
dependence of margination efficiency on particle size and shape remains largely unexplored so far.
The role of particle size and shape in the efficient delivery is a multi-faceted problem. Large enough particles
with a characteristic diameter (Dp) greater than about 4 mmmay become trapped in the smallest capillaries of the
body23. In addition, recent experiments suggest that large particles with Dp *w 3 mm are subject to an enhanced
phagocytosis24. However, recent microfluidic experiments25 have shown that spheres with the size of 2 mmshow a
significantly higher adhesion density than particles with a size of 200 nm and 500 nm. Other experiments26
indicate that liposomes with Dp , 70 nm and Dp . 300 nm have shorter circulation times than those having
an intermediate size of Dp< 150–200 nm. Furthermore, nano-particles with a size below 20–30 nm are rapidly
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excreted through the kidneys27. Experiments with discoidal part-
icles28 have shown that they accumulate in the organs better than
their spherical counterparts; however, particle internalization by
macrophages appears to be worse for elongated particles29.
Adhesion of different particles has been studied experimentally30,31
and theoretically32,33, with the result that oblate ellipsoids are subject
to stronger adhesion than spheres with the same volume. To better
understand the adhesion potential of micro- and nano-particles, a
quantitative description of particle margination under realistic blood
flow conditions is required.
In this work, we investigate the role of particle size and shape on
themargination efficiency, and therefore on their adhesion potential.
Several sizes ranging from about hundred nanometers to a few
micrometers and two different shapes (spherical and ellipsoidal)
are considered. The margination of micro- and nano-particles is
studied numerically for a wide range of hematocrit values, vessel
sizes, and flow rates using a combination of two-dimensional (2D)
and three-dimensional (3D) models. Our results indicate that large
particles possess a larger probability of being marginated than small
particles. As the particle size becomes very small (less than about
100–200 nm), the particle distribution within vessel cross-section
can be described well by the plasma volume around flowing RBCs.
Furthermore, spherical particles marginate better than ellipsoids,
however the adhesion efficiency of ellipsoidal particles is expected
to be superior in comparison to that of spheres due to their slower
rotational dynamics near a wall. Finally, we discuss what size and
shape of micro- and nano-carriers may be best suited for biomedical
applications.
Results
Blood is modeled as a suspension of RBCs and micro- or nano-
particles, while blood flow is studied in idealized microvessels using
simulations in 2D and 3D, see Fig. 1 and Methods section for details.
The 3D blood model has been shown to properly capture essential
properties of blood flow in microchannels34 as well as blood rheolo-
gical characteristics35,36. To studymicro- and nano-particle margina-
tion for a wide range of conditions, we also exploit a 2D blood flow
model due to its numerical efficiency; however, we will show that the
2D model is able to qualitatively reproduce the required blood flow
characteristics and the particle margination effect in comparison
with the 3D model.
Blood flow characteristics. The simulated system corresponds to a
cylindrical microvessel in 3D with the diameterW or to a channel in
2D with the widthW. We focus here on channel widthW5 20 mm,
but the cases ofW 5 10 mm and W 5 40 mm are also discussed. In
flow direction, periodic boundary conditions are assumed and blood
flow is driven by a constant force applied to all solvent particles,
which is equivalent to a prescribed pressure drop. The hematocrit
Ht is defined as the volume fraction of RBCs. To characterize the flow
strength, we define a non-dimensional shear rate in both 2D and 3D
as
_c~_ct~_c
gD3r
kr
, ð1Þ
where _c~v=W is the average shear rate (or pseudo shear rate) and v
is the average flow velocity computed from the flow rate, while t
defines a characteristic RBC relaxation time. Here, g is the
solvent’s dynamic viscosity, Dr~
ffiffiffiffiffiffiffiffiffiffiffi
A0=p
p
in 3D and Dr 5 L0/p in
2D are the corresponding RBC diameters, where A0 is the RBC
surface area in 3D and L0 is the cell contour length in 2D, and kr is
the RBC membrane bending rigidity. The RBCs are further
characterized in 2D by the reduced area A~4A0

pD2r
 
~0:46,
and in 3D by the reduced volume V~6V0

pD3r
 
~0:64, where
A0 is enclosed RBC area in 2D and V0 is the enclosed RBC volume in
3D. Typical values for healthy RBCs areDr5 6.5 mm in 3D, whileDr
5 6.1 mm in 2D, g5 1.23 1023 Pa s, and kr lies within the range of
50–70kBT for the physiological temperature T 5 37uC. Suspended
micro- and nano-particles are characterized by the diameter for
spheres and by the long axis for disks, denoted Dp in both cases.
Particle margination in 2D and 3D. Margination of micro- and
nano-particles in blood flow depends on Ht, W, and _c
.
Figures 2(a),(b) illustrate the distribution of carriers of size Dp 5
0.28Dr (1.83 mm) for two Ht values in 3D. For better visibility, the
carrier positions from a few snapshots are superimposed in the plot.
The carrier surfaces are colored according to their radial position in
the channel, with yellow color indicating a position near the channel
center, while blue color corresponds to a position near the wall.
Clearly, the carriers are marginating better for the case of larger Ht.
Carrier positions in blood flow sampled over time lead to particle
distributions, which reflect the probability of a particle to be at a
certain distance from the wall. Figure 2(c) shows several center-of-
mass distributions of circular particles in 2D with Dp 5 0.3Dr
(1.83 mm) for several Ht values and _c
<29:3. The RBC-free layer
(RBCFL) thickness, which is computed from simulation snapshots
through the analysis of the RBC core boundary34 similar to experi-
mental measurements37 (see Supplementary Fig. S1), is depicted by
small arrows. The distributions have been averaged over the halves of
the channel due to symmetry. Figure 2 shows that the carriers
migrate into the RBCFL and remain quasi-trapped there. With
increasing Ht, the carriers marginate better, as indicated by the
development of a strong peak in the distribution near the wall at
y/W 5 0, and the motion of the peak position towards the wall.
This is due to a decrease in the RBCFL thickness leading to a smaller
available space for the particles. This trend is in agreement with
experimental observations17 and simulations38–40 of margination of
blood platelets, which have a comparable size.
To quantify and compare particle margination for a wide range of
flow and particle parameters, we define the margination probability
as a fraction of particles whose center-of-mass is located within the
near-wall layer of thickness d. The choice of d depends on the exact
problem to be addressed, and several possibilities can be considered.
To describe particle margination into the vicinity of a vessel wall, it is
natural to select d to be the RBCFL thickness. Typical values of
RBCFL thickness and their dependence on Ht are displayed in
Supplementary Fig. S2. Figures 3(a),(b) present margination prob-
ability diagrams of particles for a wide range of Ht and _c
 values
corresponding to 3D and 2D simulations, respectively; the compar-
ison shows that roughly _c3D<1:2 _c

2D. Particle margination strongly
depends on Ht as well as on shear rate. At low Ht values, particle
margination is expected to be weak, while at highHt the margination
might be also attenuated due to particle-RBC interactions near awall.
The latter effect has been described for a marginating white blood
Figure 1 | Snapshots of cell and particle conformations in microchannels
in 3D and 2D. RBCs are colored in red and suspended particles in blue. (a)
3D simulation snapshot of blood flow for Ht 5 0.3 and _c
<39. (b) 2D
simulation snapshot of blood flow for Ht 5 0.3 and _c
<29:3.
www.nature.com/scientificreports
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cell41 and is expected to subside for particles substantially smaller
than a RBC, i.e. of sub-micrometer size. A pronounced dependence
of particle margination on shear rate is observed at low flow rates. In
the limit of very small flow rates (_c *v 1), the RBC distribution
should be nearly uniform, and therefore, the RBCFL and conse-
quently particle margination should almost vanish. As the shear rate
is increased, the RBCFL thickness grows rapidly42, leading to a sub-
stantial increase in particle margination.
The simulated values of _c cover the range of flow rates character-
istic for the venular part of microcirculation (_c *v 80 s
{1 for W <
20 mm), where it is estimated that _c *v 90 in 3D (_c *v 77 in 2D),
while in arteriolar part the flow rates are higher ( _c *w 110 s{1 for
W< 20 mm) with _c *w 120 in 3D43,44. The considered range of shear
rates is also relevant for tumor microvasculature, since blood flow
velocities in tumors are much reduced in comparison to those under
normal conditions, due to high geometric resistance and vessel per-
meability45,46. Furthermore, the margination probability diagrams in
Figs. 3(a),(b) show that the strongest particle margination occurs in
the range of Ht 5 0.25–0.6. This region has a considerable overlap
with the characteristic hematocrits in the body’s microvascular net-
works in the range Ht 5 0.2–0.4. A strong particle margination at
highHt values seems to be an advantage for drug delivery to tumors,
since blood within tumor microvasculature is often subject to hemo-
concentration due to plasma leakage47. We also note that particle
margination obtained from 3D simulations displays a higher mar-
gination probability at lowerHt values than that in the corresponding
2D system. This difference arises from the variation in RBCFL thick-
nesses in 2D and 3D systems. Thus, RBCFLs in 3D tubes are thinner
than those in 2D channels for the same Ht values due to cylindrical
curvature of the geometry, which affects close-packing of flowing
RBCs. In order to relate simulations with similar RBCFL thicknesses,
3D margination data should be compared with 2D data at a larger
hematocrit (by about 0.1–0.2), see Supplementary Fig. S2. In addi-
tion, the 3D data also shows a decrease of particle margination at
Figure 2 | Particle distributions in blood flow. Illustrations of 3D simulations of blood flow for the shear rate of _c<59 and different hematocrit values (a)
Ht 5 0.2 and (b) Ht 5 0.4. RBCs are drawn in red, while spherical carriers with a size of Dp 5 0.28Dr (1.83 mm) are colored according to their
radial position r. For better contrast, carrier positions from several time instances are superimposed in the plots. (c) Center-of-mass distributions of
carriers for various Ht values at _c
<29:3. 2D simulation results for circular particles with Dp 5 0.3Dr (1.83 mm). The wall is at y/W 5 0. The arrows
indicate the boundary of the RBCFL for the different hematocrits, marked by corresponding colors.
Figure 3 | Particle margination in 3D and 2D. Probability diagrams of particle margination with respect to _c and Ht in (a) 3D and (b) 2D, where the
margination probability is defined as a probability of a particle center-of-mass to be within the RBCFL. The white squares (%) indicate the values ofHt
and _c for which simulations have been performed.
www.nature.com/scientificreports
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high shear rates. Nevertheless, both 2D and 3D simulations show
qualitatively similar trends for the dependence of carriermargination
onHt and _c
. Therefore, we conclude that 2D simulations are able to
properly capture particle margination properties in blood flow.
Further, we will often employ a 2D system due to its robustness
and low computational cost in comparison with a 3D system.
Dependence of margination on particle size. The discussion above
considered the margination of micron-size particles. There is also a
strong interest in nano-carriers, with sizes starting from several
nanometers. Figures 4(a),(b) show margination diagrams of
particles with Dp 5 0.15Dr (0.91 mm) and Dp 5 0.04Dr (250 nm),
respectively. The comparison of Figs. 4(a),(b) and Fig. 3(b) for Dp5
0.3Dr (1.83 mm) reveals that the region of high margination
probability becomes smaller with decreasing particle size. To
illustrate the reason for the reduction in margination probability
with decreasing particle size, we present in Fig. 4(c) the
distributions of particles with different sizes for Ht 5 0.3 and
_c<29:3. For large enough particles, we observe a pronounced
peak in the distribution next to the wall due to their interactions
with RBCs, since their size is comparable with the RBCFL
thickness. Even though small particles are also marginated, their
distribution within the RBCFL is more uniform and their presence
around the vessel center line is more probable than that for larger
particles. Thus, the cumulative probability for a single particle to be
within the RBCFL is lower for nano-carriers than that for micro-
particles. Recent in vivo experiments48 also support our numerical
observations that particles with a size of about 1 mm are located
closer to the vessel wall than smaller nano-particles. Noteworthy is
that the distribution of the smallest particles withDp5 0.04Dr closely
approaches the distribution computed as the excess fluid volume of
flowing RBCs. This indicates that the distribution of particles smaller
in size than roughly 250 nm can be well approximated by the
distribution of the blood plasma, and therefore, their margination
properties can be directly inferred from local Ht distributions.
To decide on a suitable particle size for efficient drug delivery, a
number of different considerations have to be taken into account. A
direct interpretation of probabilities in Figs. 3(b) and 4(a),(b) sug-
gests that larger particle sizes are more favorable for drug delivery
due to their better margination properties. To further support this
proposition, we consider another definition for the margination
probability based on d5 0.5Dp1 s, which characterizes the fraction
of carriers whose closest surface point is not further away from the
wall than a distance s. We denote such a layer as ‘‘potential adhesion
layer’’, since particle margination into a thin near-wall layer is a
necessary precondition for adhesion. Even though the distance s is
motivated by direct receptor-ligand interactions which occur within
several nanometers, resolution restrictions in our mesoscale simu-
lation approach do not allow the selection of smaller distances than
approximately s 5 0.031Dr in 3D or s 5 0.033Dr in 2D, which
corresponds to about 200 nm. Nevertheless, the distance of several
hundred nanometers becomes relevant for particle-wall interactions
in case of a carrier whose surface is decorated by tetheredmolecules49.
Another definition formargination probability can also be based on a
fixed layer thickness d, thus it does not depend on Ht or on particle
size. Margination diagrams for this definition are illustrated in
Supplementary Fig. S3.
Figure 5(a) presents the margination probability into the potential
adhesion layer (ps) in 2D at _c
<29:3. At very smallHt, the fraction of
particles within the potential adhesion layer is small for all particle
sizes; however, the smallest studied particles seem to be slightly more
advantageous here. Remember that the interpretation of 2D mar-
gination data for a RBCFL thickness with respect to the same RBCFL
thickness in 3D requires a shift in Ht values such that the range of
Ht5 0.15–0.4 in 3D corresponds to approximately the range ofHt5
0.3–0.6 in 2D. For the range ofHt5 0.3–0.6, Fig. 5 clearly shows that
Figure 4 | Dependence of margination on particle size. Probability diagrams of particle margination in 2D for various Ht and _c values and for circular
particles with the sizes (a) Dp 5 0.15Dr (0.91 mm), (b) Dp 5 0.04Dr (0.25 mm). The white squares (%) indicate the values of Ht and _c for which
simulation were performed. The margination probability is calculated based on the RBCFL thickness. (c) Distribution of particles with different sizes
across the channel forHt5 0.3 and _c
<29:3. For small particles the distribution resembles the black solid curve computed as the blood-plasma volume.
The arrow denotes position of the RBCFL boundary.
www.nature.com/scientificreports
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the fraction of large particles within the potential adhesion layer is
much higher than that for small particles. The corresponding mar-
gination diagrams are shown in Figs. 5(b–d) and support the con-
clusion that large particles marginate better for all considered shear
rates. This indicates thatmicro-carriers are likely to be better for drug
delivery than sub-micron particles.
Dependence ofmargination on vessel size.To elucidate the effect of
vessel diameter, we performed a number of simulations in 2D for two
additional channel widths (W5 10 mmand 40 mm) and two particle
sizes (Dp 5 0.15Dr and Dp 5 0.3Dr); corresponding simulation
snapshots are displayed in the Supplementary Fig. S4. We consider
margination into both the RBCFL and the potential adhesion layer.
The pronounced dependence of particle margination properties
on channel width for the potential adhesion layer is illustrated by a
comparison of Fig. 5(b) and Fig. 6. For particles with a size of Dp 5
0.3Dr (1.83 mm), particle margination into the potential adhesion
layer improves considerably as the channel size decreases due to
the much smaller RBCFL thickness in narrow channels. Thus, par-
ticle adhesion is expected to be more efficient in small vessels (i.e.,
capillaries) than in large vessels (i.e., venules and arterioles).
Supplementary Fig. S5 supports this observation for particles with
Dp 5 0.15Dr (0.91 mm). Furthermore, a reduction of margination
into the potential adhesion layer with decreasing particle size is
found for all channel sizes.
Particle margination based on the RBCFL thickness exhibits sim-
ilar dependence onHt and flow rate for different channel widths, see
Supplementary Fig. S6. For the channel widthW5 10 mm,margina-
tion into the RBCFL differs only slightly for different particle sizes up
toHt< 0.5. ForHt *w 0:5, the particle radius might be larger than the
RBCFL thickness, leading to an apparent decrease inmargination for
the large particles. For the cases W 5 20 and 40 mm, where the
RBCFL thickness is always larger than the particle radius, we observe
that large particles marginate clearly better than small particles.
Dependence of margination on particle shape.Advances in micro-
and nano-particle fabrication facilitate the production of carriers of
various shapes, including spherical, prolate and oblate ellipsoidal,
and rod-like shapes5. However, advantages of different particle
shapes for drug delivery are still to be explored. Thus, we
investigate the effect of shape on the margination properties in
blood flow. Figure 7 displays results of simulations in 2D for the
margination probability (based on the RBCFL) of elliptic particles
under various blood flow conditions in comparison to circular
particles. The ellipse has an aspect ratio of about 7 and the longest
diameter isDp5 0.63Dr (3.84 mm); the enclosed area corresponds to
the area of a circle with diameter Dp 5 0.22Dr (1.35 mm). The plot
indicates that margination of elliptic particles is slightly worse than
that of circular particles. From these data we can also conclude that
margination of the elliptic particles with a smaller aspect ratio than 7
is similar to that presented in Fig. 7. However, since the largest
Figure 5 | Margination into a potential adhesion layer of thickness 200 nm. (a) Margination probability ps. The curves correspond to different particle
sizes, where Dp 5 0.63Dr (3.84 mm) is for an elliptic particle and the other curves are for circular particles. 2D simulation results for _c
<29:3. (b–d)
Margination diagrams for (b) Dp 5 0.3Dr (1.83 mm) (c) Dp 5 0.15Dr (0.91 mm), and (d) Dp 5 0.04Dr (0.25 mm).
Figure 6 | Margination for different channel widths.Margination into the potential adhesion layer based on d5 0.5Dp1 200 nm, for particles with size
Dp 5 0.3Dr (1.83 mm) and two channel widths (a) W 5 10 mm and (b) W 5 40 mm.
www.nature.com/scientificreports
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diameter of the ellipse is larger than that of a circle with the same area,
its margination into the potential adhesion layer, which is defined as
a probability of a particle to be within a near-wall layer of thickness
d5 0.5Dp1 200 nm, appears to be considerably larger for ellipsoids
than that for the corresponding sphere (see Fig. 5). We have also
performed a number of 3D simulations with oblate ellipsoids having
the same aspect ratio, which showed that their margination is
qualitatively similar to that in 2D.
Recent theoretical32,33 and experimental30,31 studies suggest that
ellipsoidal particles possess better adhesion properties than spheres
due to a larger contact area for adhesion interactions. It is also inter-
esting to consider drag force on an ellipsoid or sphere in shear flow
near a wall. In case of an ellipsoid close and parallel to a wall, the drag
force is found to be smaller than that on a sphere with the same
volume, which was estimated in separate simulations of a sphere
and an ellipsoid in shear flow with fixed position. Thus, adhered
ellipsoidal particles experience a lower drag force due to fluid flow
than the corresponding spheres with the same volume. In conclu-
sion, the current knowledge about adhesion of ellipsoidal particles
and our simulation results on margination suggest that ellipsoidal
particles are very likely a better choice for drug delivery than spher-
ical particles.
Dynamics of marginated particles. Local particle dynamics may
also influence the margination and adhesion efficiency. Simula-
tions in 3D show that the dynamics of marginated particles (i.e.,
within the RBCFL region) is different for spherical and ellipsoidal
particles. A spherical particle is subject to a uniform rotation, while
an ellipsoid displays tumbling dynamics. A quantitative analysis of
the average angular velocities Ævæ of marginated particles shows that
ellipsoidal particles rotate considerably slower within the RBCFL
than spherical carriers, see Fig. 8. The comparison is made for a
sphere and an ellipsoid of the same volume, while the long
semiaxis of the ellipsoid is about twice the radius of the sphere.
Within the RBCFL region it is plausible to assume a simple shear
flowwith the wall shear rate _cw, which can be computed directly from
a near-wall velocity profile or estimated from the pressure gradient
applied to drive the flow. In Fig. 8, we compare the average angular
velocities of marginated spherical and ellipsoidal particles with the
theoretical predictions by Jeffery50 for an oblate ellipsoidal particle in
shear flow, which is given by
vh i~ _cw
rez1=re
, ð2Þ
where re is the aspect ratio ofmajor andminor axis. For a sphere, re5
1 which impliesvs~ _cw=2, while for an ellipsoid, re5 7 which results
in ve<0:14 _cw, such that ve , vs. In addition, while the results for
Ævæ in Fig. 8(a) for a sphere are close to the theoretical results, the
computed angular velocities for an ellipsoid in Fig. 8(b) are lower
than the corresponding theoretical predictions due to the
confinement of the ellipsoid between the wall and flowing RBCs. A
lower rotational velocity of a particle leads to a longer interaction
time between the particle and a wall. Thus, adhesion of ellipsoidal
particles is expected to be more efficient than for spheres with a
comparable size. In conclusion, a detailed analysis of dynamics of
marginated particles further supports the proposition that ellipsoidal
particles are likely to be better candidates for drug delivery.
Discussion
Particle margination in blood flow depends on particle size and
shape, hematocrit, vessel size, and flow rate.Margination of spherical
and ellipsoidal particles increases with increasing hematocrit, while
their margination properties appear to be rather similar, where a
sphere marginates slightly more efficient than an ellipsoid. The pre-
sented diagrams show that larger particles have a highermargination
probability in comparison to the smaller ones. Moreover, the distri-
bution of very small particles with a diameter smaller than approxi-
mately 250 nm is well represented by the blood plasma volume of
RBCs. Margination of particles into the potential adhesion layer is
found to be more pronounced in small vessels, indicating that par-
ticle adhesion is likely to occur more often in capillaries than in
arterioles and venules.
The simulation results are in good qualitative agreement with
several experimental observations15,17,25,30,31,48. For example, margina-
tion of micro-particles has been observed to be more efficient than
that of nano-particles in recent in vivo experiments48. However, a
detailed quantitative comparison is still difficult due to two reasons.
On the one hand, the majority of the simulation results is obtained
for 2D systems, which provide interesting insights into the relevant
mechanisms, but have limited power for quantitative predictions for
3D systems. On the other hand, experimental data on particle mar-
Figure 7 | Dependence of margination on particle shape. Margination
probabilities of ellipse-like particles (dashed lines) for various Ht and _c

values in comparison to circular particles (solid lines) of the same area. The
long axis of a 2D elliptic particle is Dp5 0.63Dr (3.84 mm) and the aspect
ratio equals approximately 7. The margination probability is calculated
based on the RBCFL thickness.
Figure 8 | Dynamics ofmarginated spherical and elliptical particles within theRBCFL.Comparison of average angular velocities Ævæof (a) spherical and
(b) ellipsoidal particles for various wall shear rates _cw in 3D. The simulation results Ævæ (solid lines) are also compared with the theoretical
prediction (dashed lines) by Jeffery50 for a particle in simple shear flow.
www.nature.com/scientificreports
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gination in blood flow15,48 are very scarce and most of the available
experimental investigations (e.g., Refs. 25, 30, 31) focus on carrier
adhesion. Even though margination is a necessary pre-condition for
particle adhesion to vessel walls, particle margination and adhesion
are not equivalent, since carrier adhesion may also depend on other
factors (e.g., specific targets, the receptor/ligand density and
distribution).
Clearly, the size and shape of drug carriers are important para-
meters not only for margination, but also for their adhesion and
further transport through biological barriers (e.g., internalization).
Our simulations suggest that ellipsoidal particles are expected to
adhere more efficiently than spherical carriers due to a larger surface
for adhesive interactions and decelerated tumbling motion within
the RBCFL. Therefore, our future numerical investigations will be
focused on the adhesion ability of various particles in blood flow.
Further requirements for efficient drug delivery include particle
transport through vessel walls, interstitial space, and cell membranes.
For instance, particle internalization by endothelial cells and intra-
cellular trafficking have been shown to be most efficient for spherical
sub-micron particles, rather than for micron-size carriers with an
ellipsoidal shape10. This observation points in the direction of smaller
carrier to be most efficient for internalization. As a consequence, the
concept ofmulti-stage drug-delivery carriers1,7, where a largermicro-
particle incorporates a number of small nano-carriers, seems to be
very promising. In this way, margination and carrier delivery or
adhesion to a specific target within the microvasculature could be
achieved using micro-particles, which would then be followed by the
release of nano-particles into the tissue. In conclusion, tackling vari-
ous drug-delivery challenges is a complex issue; its resolution
requires an inter-disciplinary effort including in vitro and in vivo
experiments and realistic numerical simulations.
Methods
Simulationmethod.We employ the dissipative particle dynamics (DPD)method51,52
for 2D simulations and the smoothed DPD (SDPD) method53 for 3D simulations,
where both methods are mesoscopic particle-based simulation approaches which
properly capture hydrodynamics. Both simulated systems are represented by a
collection of n point particles. The particles interact locally within a selected cutoff
region through three pairwise forces denoted as conservative (FC), dissipative (FD),
and random (FR) forces. The time evolution of the velocity vi and position ri of particle
iwith the massmi is determined by the Newton’s second law of motion dri5 vidt and
dvi~
1
mi
FCi zF
D
i zF
R
i
 
dt. More information on the DPD formulation can be found
in Refs. 51, 52, while the DPD parameters used in 2D simulations are presented in
Supplementary Tab. 1.
In the SDPDmethod, the forces are derived by a discretization of the Navier-Stokes
equation similar to the smoothed particle hydrodynamics (SPH) method54, while the
implementation of thermal fluctuations is analogous to that in DPD53. The forces on
particle i are given by the conservative force FCi ~
X
j
pi
r2i
z
pj
r2j
 !
vijrij , the
dissipative force FDi ~{
X
j
cij vijzr^ij r^ij
:vij
 
, and the random force
FRi~
X
j
sij dWijz 13 tr dWij
  	:^rij . Thereby, dWij is a matrix of independent
Wiener increments and dWij is its traceless symmetric part. Here, pi and pj are particle
pressures which are given by the equation of state p5 p0(r/r0)a2 bwith p0, r0, a, and
b being model parameters, see Supplementary Tab. S2. The particle density ri is
calculated locally as ri~
X
j
W rij
 
, where W rð Þ~ 105
16pr3c
1z3
r
rc
 	
1{
r
rc
 	3
is
the Lucy function54 and rc is the cutoff radius. The weight function w(r) is determined
by =W(r)52rw(r). The coefficients cij and sij define the strength of dissipative and
random forces. The fluctuation-dissipation theorem to be satisfied requires
sij~2
ffiffiffiffiffiffiffiffiffiffiffiffi
kBTcij
q
. Finally, the friction coefficients are defined as cij~
5g0
3
w rij
 
rirj
.
Blood components. In 3D, a RBC membrane and suspended carriers are both
modeled by a collection of discrete points, which are the vertices of a triangular
network of springs on their membrane surface55. The network assumes fixed
connectivity with the potential energy defined as
Umembrane~UspringzUbendzUareazUvol, ð3Þ
which includes the spring’s elastic energy Uspring, the bending energy Ubend, and the
area and volume conservation constraintsUarea andUvol. The spring forces mimic the
elasticity of a membrane. The bending energy represents the bending resistance of a
membrane, while the area and volume energies enforce area-incompressibility of a
membrane and incompressibility of the inner cytosol, respectively. Detailed
description of these potentials can be found in Ref. 55, while all model parameters are
given in Supplementary Tab. S3.
In 2D, RBCs and micro- and nano-particles are modeled as closed bead-spring
chains, which incorporate bending rigidity and an area constraint41. The model
parameters are presented in Supplementary Tab. S4. Carriers in 2D are modeled by a
collection of Npv particles (see Supplementary Tab. S5), which are constrained to
maintain a rigid configuration.
Simulation setup. The simulation setup consists of a single channel of cylindrical
shape in 3D with diameter W 5 20 mm and length of L 5 12.3Dr. In 2D, a slit
geometry with different widths W 5 10, 20, and 40 mm and length L 5 19.5Dr
(independent ofW) is employed. The channel is filled with fluid particles and with N
suspended carriers and NRBC RBCs. The number of RBCs is computed according to
channel hematocrit, which corresponds to the volume fraction of RBCs in 3D and to
the area fraction of RBCs in 2D. The number of suspended particles for different
simulations is provided in Supplementary Tab. S5.
Boundary conditions. In the flow direction, periodic boundary conditions (BCs)
were imposed, while in the other directions the suspension was confined by walls. The
walls are modeled by frozen fluid particles with the same structure as the fluid, while
the wall thickness is equal to rc. Thus, the interactions of fluid particles with wall
particles are the same as the interactions between fluid particles, and the interactions
of suspended carriers and cells with the wall are identical to those with a suspending
fluid. To prevent wall penetration, fluid particles as well as vertices of RBCs and
carriers are subject to reflection at the fluid-solid interface. We employed bounce-
back reflections, because they provide a better approximation for the no-slip
boundary conditions in comparison to specular reflection of particles. To ensure that
no-slip boundary conditions are strictly satisfied, we also add a tangential adaptive
shear force56 which acts on the fluid particles in a near-wall layer of a thickness hc5 rc.
Coupling between solvent and cells/carriers. Coupling between the fluid flow and
cells/carriers is achieved through viscous friction55 between cell vertices and the
surrounding fluid particles, which is implemented via the DPD interactions FD and FR
for both 2D and 3D simulations. The strength c of the dissipative force FD for the
interaction between a fluid particle and amembrane vertex is computed such that no-
slip BCs are ensured. The derivation of c is based on the idealized case of linear shear
flow over a flat part of a membrane with area A. In a continuum hydrodynamics
description, the total shear force exerted by the fluid on the area A is equal to Ag _c,
where g is the fluid’s viscosity and _c is the local wall shear-rate. The same fluid force
has to be also transmitted onto a discrete membrane having NA vertices within the
area A. The force on a single membrane vertex exerted by the sheared fluid can be
found as Fv~
ð
Vh
ng rð ÞFDdV where n is the fluid number density, g(r) is the radial
distribution function of fluid particles with respect to themembrane particles, andVh
is the half sphere volume of fluid above the membrane. Here, the total shear force on
the area A is equal toNAFv. The equality ofNAFv~Ag _c results in an expression of the
dissipative force coefficient in terms of the fluid density and viscosity, wall density
NA/A, and rc. Under the assumption of linear shear flow the shear rate _c cancels out.
This formulation results in satisfaction of the no-slip BCs for the linear shear flow
over a flatmembrane; however, it also serves as an excellent approximation for no-slip
at the membrane surface. Note that conservative interactions between fluid and
membrane particles are turned off, which implies that the radial distribution function
is structureless, g(r)5 1. In 2D, the surface area is replaced by a line of length L with
NL particles, and the half sphere volume is replaced by the half circle area Av.
Gathering statistics. The center-of-mass distributions of particles were calculated on
the fly and were written to disk as sub-averages over short time intervals. Final
averaging of the data is done during post-processing. To make sure that the final
averaging of data starts from a time point which is sufficiently late for the system to be
independent of the initial conditions, we have tested the sensitivity of final
distributions to the choice of the starting time for averaging.
Measuring RBC-free-layer thickness. To determine the RBC-free-layer (RBCFL)
thickness, we measure the outer edge of the RBC core shown in Supplementary Fig.
S1, which is similar to RBCFL measurements in experiments37,57. The data are
averaged for many RBC snapshots at different times. In 3D, the RBC core edge is
measured by projecting RBC vertices onto the x-y plane, where curves of the RBC core
minimum andmaximum are fitted similar to that in Supplementary Fig. S1. Here, we
also perform averaging over different angular orientations (to exploit the cylindrical
symmetry of the channel) in addition to the temporal averaging.
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